All-Trans Retinoic Acid Inhibits Vascular Endothelial Growth Factor Expression in a Cell Model of Neutrophil Activation
article
OA: bronze
CC0
⤵ 25 in-corpus citations
AI-generated summary
All-trans retinoic acid suppresses vascular endothelial growth factor expression in differentiated HL-60 cells by inhibiting transcription via a direct repeat 1 element.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Infiltrating neutrophil granulocytes are a particularly rich source of vascular endothelial growth factor (VEGF) in the endometrium and may contribute to the angiogenesis of endometriosis lesions. The objective of this study is to evaluate the expression and regulation of VEGF in endometrial neutrophils and in a model of neutrophil differentiation relevant to endometriosis. Immunohistochemistry was performed on endometriosis patient biopsies and cultured neutrophil-like HL-60 cells were assessed. The study was set in a reproductive biology division within an academic medical center. Endometrial biopsies were performed on women with endometriosis and HL-60 cells were treated with all-trans retinoic acid (atRA) and dimethyl sulfoxide in vitro. Immunofluorescence histochemistry, VEGF mRNA and protein quantification, and transfection studies of VEGF gene promoter-luciferase constructs were all main outcome measures. Immunofluorescence studies verified the presence of neutrophils in eutopic endometrium from women with endometriosis. Examination of the regulation of VEGF using differentiated HL-60 cells as a model, revealed that atRA induced a dose- and time-dependent suppression of VEGF mRNA and protein. Transient transfection, truncation, EMSA, and site-directed mutagenesis of human VEGF promoter-luciferase constructs in HL-60 cells indicated that atRA repressed VEGF gene transcription via a direct repeat 1 element located between -443 and -431 bp relative to the transcription initiation site. Because retinoic acid is synthesized de novo in endometrial cells under the influence of progesterone, our findings suggest that the up-regulated VEGF and angiogenesis in tissue from women with endometriosis may reflect failure of neutrophil differentiation in these cases, and provide a rationale for retinoid therapy in this condition.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (42)
- Angiogenic Factors in Endometriosis via openalex
- Chemokine growth-regulated-α: a possible role in the pathogenesis of endometriosis via openalex
- Endocrine and Paracrine Regulation of Endometrial Angiogenesis via openalex
- Endometriosis: Interaction of Immune and Endocrine Systems via openalex
- Epithelial neutrophil-activating peptide 78 concentrations are elevated in the peritoneal fluid of women with endometriosis via openalex
- Progesterone Receptor Isoform A But Not B Is Expressed in Endometriosis via openalex
- The vascular endothelial growth factor (VEGF) +405G>C 5′-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study via openalex
- Uterine Chemokines in Reproductive Physiology and Pathology via openalex
- Vascular endothelial growth factor A and C gene expression in endometriosis via openalex
- Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis via openalex
- W2017967258 via openalex
- W2030437674 via openalex
- W2058685595 via openalex
- W2077994180 via openalex
- W2079830319 via openalex
- W2084710737 via openalex
- W2090052676 via openalex
- W2098313671 via openalex
- W2120067155 via openalex
- W2127533559 via openalex
- W2140246703 via openalex
- W2148050205 via openalex
- W2152793184 via openalex
- W2154785421 via openalex
- W2171038620 via openalex
- W2172005240 via openalex
- W2238870413 via openalex
- W2348719021 via openalex
- W2372114319 via openalex
- W3147955859 via openalex
- W6658221620 via openalex
- W6705793852 via openalex
- W6708134258 via openalex
- W1576865226 via openalex
- W1966257589 via openalex
- W1983212124 via openalex
- W1984414986 via openalex
- W2002687754 via openalex
- W2004231366 via openalex
- W2009718333 via openalex
- W2012005683 via openalex
- W2015750265 via openalex
Cited by (25)
- An emerging role for neutrophils in the pathogenesis of endometriosis 2025
- Additional file 2 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 4 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 4 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 5 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 3 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 2 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 1 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 5 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 6 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 1 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 3 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 6 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Peritoneal immune microenvironment of endometriosis: Role and therapeutic perspectives 2023
- Neutrophils 2021
- Immunosuppression and immunotherapy in endometriosis 2021
- Comparison of the effect of isotretionin and alitretionin on endometriotic implants and serum vascular endothelial growth factor level: an experimental study 2019
- Fruit and vegetable consumption and risk of endometriosis 2018
- Retinoic acid regulates endometriotic stromal cell growth through upregulation of Beclin1 2017
- Chronic Pelvic Pain in Endometriosis: An Overview 2013
- The Efficacy of Bevacizumab, Sorafenib, and Retinoic Acid on Rat Endometriosis Model 2012
- Models of Endometriosis: Animal Models I – Rodent‐Based Chimeric Models 2011
- Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications 2010
- Dioxin may promote inflammation-related development of endometriosis 2008
Source provenance
- europepmc
- last seen: 2026-08-08T06:08:32.324769+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:15:29.922408+00:00
License: CC0
· commercial use OK